Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-On-Chronic Liver Failure (Phase 4)
Allergy and Immunology (Phase 2)
Arthritis (Early Phase 1)
Arthritis, Juvenile (Phase 2)
Arthritis, Psoriatic (Early Phase 1)
Arthritis, Rheumatoid (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Coronavirus Infections (Phase 4)
COVID-19 (Phase 4)
COVID-19 Vaccines (Phase 4)
Dermatology (Phase 2)
Dermatomyositis (Phase 2)
Drug Evaluation (Phase 3)
Fever (Phase 4)
Gout (Early Phase 1)
Healthy Volunteers (Phase 2/Phase 3)
Hematologic Neoplasms (Phase 3)
HIV (Phase 3)
Hypersensitivity (Phase 2)
Immunization (Phase 4)
Immunocompromised Host (Phase 3)
Immunosuppression Therapy (Phase 4)
Infections (Phase 1)
Inflammation (Early Phase 1)
Influenza, Human (Phase 3)
Injection Site Reaction (Phase 4)
Kidney Transplantation (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Liver Transplantation (Phase 2)
Lung Diseases (Phase 4)
Lupus Erythematosus, Systemic (Phase 2)
Lymphoma (Phase 4)
Lymphoma, Non-Hodgkin (Phase 3)
Mast Cell Activation Disorders (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 4)
Neoplasms (Phase 4)
Only Child (Phase 4)
Organ Transplantation (Phase 3)
Osteoarthritis (Early Phase 1)
Pain (Phase 4)
Pemphigus (Phase 2)
Pneumococcal Infections (Phase 3)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Psoriasis (Phase 4)
Quality of Life (Phase 4)
Renal Insufficiency, Chronic (Phase 2/Phase 3)
Respiratory Tract Infections (Phase 4)
RNA Virus Infections (Phase 1/Phase 2)
Safety (Phase 3)
SARS-CoV-2 (Phase 2)
Sclerosis (Phase 2)
Severe Acute Respiratory Syndrome (Phase 4)
Sjogren's Syndrome (Early Phase 1)
Skin Diseases, Vesiculobullous (Phase 4)
Spondylitis, Ankylosing (Early Phase 1)
Vaccination (Phase 2)
Vaccine-Preventable Diseases (Phase 4)
Vaccines (Phase 4)
Virus Diseases (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue